Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York 10065, United States.
ACS Biomater Sci Eng. 2020 May 11;6(5):2506-2517. doi: 10.1021/acsbiomaterials.9b00968. Epub 2020 Jan 28.
Photodynamic therapy (PDT) is a noninvasive cancer treatment that requires the copresence of a photosensitizer (PS), oxygen, and light. The efficacy of conventional PDT is usually limited by two factors: delivery of the PS to the tumor and the hypoxic solid tumor environment. To improve the efficacy of PDT, nanomaterial-based, enzyme-assisted PDT (nano-ezPDT), which integrates enzyme-responsive components into nanomedicines, was developed for enhanced PS delivery and oxygen generation. Nano-ezPDT is designed to take full advantage of the catalytic function of locally activated tumor-associated enzymes or smuggled exogeneous enzymes. The enhancement of PS release and accumulation is often controlled by endogenous enzymes upregulated at the tumor sites. Oxygen generation, however, relies mostly on catalase-loaded nanomedicines. In this review, we discuss the associated enzymes, constructs, and types of nanocarriers and highlight the principle and utility of nano-ezPDT for cancer therapy.
光动力疗法(PDT)是一种非侵入性的癌症治疗方法,需要光敏剂(PS)、氧气和光的共同存在。传统 PDT 的疗效通常受到两个因素的限制:PS 向肿瘤的输送和缺氧的实体肿瘤环境。为了提高 PDT 的疗效,人们开发了基于纳米材料的酶辅助 PDT(nano-ezPDT),将酶响应组件整合到纳米药物中,以增强 PS 的输送和氧气的产生。nano-ezPDT 的设计充分利用了局部激活的肿瘤相关酶或走私的外源性酶的催化功能。PS 的释放和积累的增强通常受肿瘤部位上调的内源性酶控制。然而,氧气的产生主要依赖于载有过氧化氢酶的纳米药物。在这篇综述中,我们讨论了相关的酶、构建体和类型的纳米载体,并强调了 nano-ezPDT 用于癌症治疗的原理和实用性。